American Express reports Q2 results on July 24 with the Street firmly in the bulls' corner, yet positioning data suggests much of the good news is already in the price.
Options traders are mildly more defensive than usual heading into the print. The put/call ratio ticked up to 0.63, about one standard deviation above its 20-day average of 0.60 — not an alarming reading, but a notable drift toward caution. The stock closed at $351.93, down roughly 1% on the day and flat on the week, after gaining 4% over the past month. Bears, meanwhile, have largely walked away: short interest has fallen 16% over the past month to just 1.5% of the free float, and borrow conditions remain deeply relaxed, with availability running near 8,400% — far more shares available than are currently borrowed. The ORTEX short score has also eased to 33.0, down from 35.1 two weeks ago, reinforcing the picture of retreating short conviction.
The analyst debate has shifted decisively toward bulls, though the gap between the bull and bear theses remains real. JPMorgan's upgrade to Overweight on July 13 — lifting its target from $328 to $400 — was the headline move, and it follows a broad pattern: virtually every firm active in the past three weeks has raised targets, with BofA at $391, UBS at $386, and Evercore at $380. The bull case rests on accelerating new account growth in both Consumer and Commercial segments, which is absorbing the deceleration in same-customer spending. Bears, however, point to a decline in new card acquisitions both quarter-over-quarter and year-over-year, and argue the company needs to cut marketing meaningfully to defend its 2026 EPS targets — a move that could signal underlying business weakness rather than discipline. The consensus headline remains a hold, with 13 hold ratings and just one underperform, while the mean price target near $375 now sits only modestly above the current price. That narrow gap reflects a market that has already moved to price in the upgrade cycle.
One ownership detail adds texture. Berkshire Hathaway holds a towering 22.2% of shares — a position unchanged in the most recent filing period — anchoring the register and limiting the stock's sensitivity to short-term institutional rotation. That concentration means the earnings reaction is unlikely to be amplified by forced-seller dynamics.
The print will therefore test not whether AXP is growing, but whether new account momentum and billed business trends are strong enough to justify a stock that has already re-rated sharply — and whether the bear case on NCA weakness is a genuine headwind or just noise around a card refresh cycle.
See the live data behind this article on ORTEX.
Open AXP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
